MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma.
Wang Q, Zhao D, Xian M, Wang Z, Bi E, Su P, Qian J, Ma X, Yang M, Liu L, Zu Y, Pingali SR, Chen K, Cai Z, Yi Q.
Wang Q, et al. Among authors: xian m.
Blood. 2020 Nov 26;136(22):2557-2573. doi: 10.1182/blood.2020005795.
Blood. 2020.
PMID: 32582913
Free PMC article.